Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Gunaldi M, Duman BB, Afsar CU, Paydas S, Erkisi M, Kara IO, Sahin B. J Oncol Pharm Pract. 2016 Apr;22(2):242-7. doi: 10.1177/1078155
Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. Karaca F, Afsar CU, Gunaldi M, Erkurt E, Ercolak V, Sertdemir Y, Paydas S. Int J Clin Exp Med. 2
Utility of peripheral blood parameters in predicting breast cancer risk. Okuturlar Y, Gunaldi M, Tiken EE, Oztosun B, Inan YO, Ercan T, Tuna S, Kaya AO, Harmankaya O, Kumbasar A. Asian Pac J Cancer Prev. 2015;16(6):2409-12.
Elevated serum levels of heat shock protein 70 are associated with breast cancer. Gunaldi M, Afsar CU, Okuturlar Y, Gedikbasi A, Kocoglu H, Kural A, Akarsu C, Gunduz U, Tiken EE. Tohoku J Exp Med. 2015;236(2):97-102. doi: 10.1620/tjem.236.97.
PRAME Expression and Its Clinical Relevance in Hodgkin’s Lymphoma. Ercolak V, Paydas S, Bagir E, Ergin M, Seydaoglu G, Celik H, Yavu B, Tanriverdi K, Gunaldi M, Afsar CU, Duman BB. Acta Haematol. 2015;134(4):199-207.
Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Gunaldi M, Duman BB, Afsar CU, Paydas S, Erkisi M, Kara IO, Sahin B. J Oncol Pharm Pract. 2016 Apr;22(2):242-7. doi: 10.1177/1078155
Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. Karaca F, Afsar CU, Gunaldi M, Erkurt E, Ercolak V, Sertdemir Y, Paydas S. Int J Clin Exp Med. 2
Utility of peripheral blood parameters in predicting breast cancer risk. Okuturlar Y, Gunaldi M, Tiken EE, Oztosun B, Inan YO, Ercan T, Tuna S, Kaya AO, Harmankaya O, Kumbasar A. Asian Pac J Cancer Prev. 2015;16(6):2409-12.
Elevated serum levels of heat shock protein 70 are associated with breast cancer. Gunaldi M, Afsar CU, Okuturlar Y, Gedikbasi A, Kocoglu H, Kural A, Akarsu C, Gunduz U, Tiken EE. Tohoku J Exp Med. 2015;236(2):97-102. doi: 10.1620/tjem.236.97.
PRAME Expression and Its Clinical Relevance in Hodgkin’s Lymphoma. Ercolak V, Paydas S, Bagir E, Ergin M, Seydaoglu G, Celik H, Yavu B, Tanriverdi K, Gunaldi M, Afsar CU, Duman BB. Acta Haematol. 2015;134(4):199-207.